New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 27, 2020 - The FDA approved Sun Pharmaceuticals’ Ultravate (halobetasol propionate) lotion, for the topical treatment of plaque psoriasis in patients twelve (12) years of age and older.
Download PDF
Return to publications
